Recall Register

Device recall: Cobas KRAS Mutation Test for In Vitro Diagnostic Use Product Usage: Usage: The Cobas KRAS Mutation Test, for use with…

Class III FDA enforcement event 62500. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

During the real-time stability testing for the cobas KRAS Mutation Test on the commercial lot PO6778, it was identified that the kit was just within specifications for the codon 61 peak height ratio, and that the kit has trended towards the upper specification limit at the 6 month time point but did passed the 6 month stability testing. The kit is labeled for 9 months shelf life stability. The d

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Roche Molecular Systems, Inc. started this device recall on 24 Feb 2012. The firm address in the FDA record is in Branchburg, NJ. FDA put the recall in Class III. FDA event 62500 has 1 product record. The first FDA enforcement report date is 15 Aug 2012. The record gives the status Terminated, with the termination date 16 Jul 2013.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide Distribution - including the countries of Austria, Belgium, Czech Republic, Denmark, Germany, Italy, Luxemburg, Netherlands, Poland, Slovakia, Slovenia, Spain, United Kingdom, Canada,…

Recalling firm

Roche Molecular Systems, Inc., Branchburg, NJ.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 62500: product records
Recall numberProductQuantityClassStatusReport date
Z-2159-2012Cobas KRAS Mutation Test for In Vitro Diagnostic Use Product Usage: Usage: The Cobas KRAS Mutation Test, for use with the Cobas 4800 System, is a real-time PCR test intended for the identification of mutations in codons 12, 13 and 61 of the KRAS gene in DNA derived from formalin-fixed paraffin-embedded human…264 kits to 13 EU countries; 2 kits to Canada and 33 kits to 11 countries in the Rest of the WorldClass IIITerminated15 Aug 2012

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Device events that started in 2012
823
Share of these events in Class III
6%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
30

Other events of the firm

Other FDA enforcement events of Roche Molecular Systems, Inc.
InitiatedProduct (first record)TypeClassRecords
21 Dec 2022cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190DeviceClass II3
8 Sep 2022cobas 5800 instrument, Material No. 08707464001. Used for automated Polymerase Chain Reaction (PCR) based Nucleic Acid TDeviceClass II1
16 Nov 2021cobas LiatSystem, respiratory virus panel nucleic acid assay system, Material Number 07341920190DeviceClass II1
3 Sep 2021cobas EGFR Mutation Test v2-Somatic gene mutation detection system Catalog Number :07248563190DeviceClass II1
4 Aug 2021cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat System, Catalog Number 09211101190DeviceClass II1
25 Mar 2021cobas SARS-CoV-2 & Influenza A/B assay cobas Liat- Reagents, 2019-Novel Coronavirus Nucleic Acid for use on the cobas LiDeviceClass II2
23 Nov 2020uPath software 1.1 and uPath software 1.1 IVD-INSW, Material numbers 08991871001 and 09077332001DeviceClass II1
19 Nov 2020The cobas z 480 analyzer including dedicated software for IVD use is a plate-based automated amplification and detectionDeviceClass II1
3 Jun 2020MagNA Pure 96 Instrument, clinical sample concentrator, Material number 06541089001 - Product Usage: This protocol is inDeviceClass II1
2 May 2018MagNA Pure 24 System, GMMI: 07290519001 Product Usage: The MagNA Pure 24 System is a fully automated clinical sample extDeviceClass II1

Roche Molecular Systems, Inc.: all 30 events

Official channels

Cite this page

Recall Register. FDA enforcement event 62500. https://recallregister.com/fda/iii/62500/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide Distribution - including the countries of Austria, Belgium, Czech Republic, Denmark, Germany, Italy, Luxemburg, Netherlands, Poland, Slovakia, Slovenia, Spain, United Kingdom, Canada,…
What quantity of product is in FDA event 62500?
The FDA record gives this quantity: 264 kits to 13 EU countries; 2 kits to Canada and 33 kits to 11 countries in the Rest of the World
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2012 have the same class?
6% of the 823 device events that started in 2012 are in Class III.